Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid...
FDA Approves Updated Altuviiio Label With Expanded Pediatric Data Confirming Highly Effective Bleed Protection in Children With Hemophilia
The US Food and Drug Administration (FDA) has updated the label for Altuviiio® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]...
U.S. Drug Overdose Deaths Decline for First Time in 7 Years
The relentless rise in deaths from drug overdose in the United States may finally have stalled: New data from 2023 show the first decline in such deaths...
Avian Flu Virus Showing Up in NYC Wild Birds
The H5N1 avian flu virus has been discovered in a small number of wild birds in New York City.The highly infectious and severe virus was detected in fecal...
New Blood Test Could Help Spot Preeclampsia in First Trimester
Preeclampsia can be a life-threatening complication of pregnancy, but a new blood test can help predict a woman's risk for the condition while she is in...
Report Highlights Big Gaps in Cancer Outcomes Based on Race
U.S. cancer death rates are continuing to drop, falling by 33% between 1991 and 2020.However, not all Americans are reaping the benefits from advances...
First Patient Dosed in Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer
AUSTIN, Texas, May 14, 2024. Genprex, Inc. ("Genprex" or the "Company"), a clinical-stage gene therapy company focused on developing life-changing therapies...
High Telehealth Use Tied to Increased Health Care Utilization, Cost
Higher telehealth use in a hospital service area is tied to increased health care utilization and cost, according to a study published online May 13 in JAMA...
Heatwave Exposure Linked to Considerable Mortality Burden
Heatwaves are associated with a considerable mortality burden, with geographic disparities apparent, according to a study published online May 14 in PLOS...
Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using...
Child Maltreatment Linked to Externalizing, Internalizing Behavior
Child maltreatment is associated with increases in externalizing and internalizing behaviors, according to a study published online May 14 in Pediatrics. Anneke...
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer
SHANGHAI, May 13, 2024, Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study...
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism
Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) notified the Company that information submitted in...
FDA Safety Communication: Do Not Use Cue Health’s COVID-19 Tests Due to Risk of False Results
The U.S. Food and Drug Administration (FDA) is warning home test users, caregivers, and health care providers not to use Cue Health’s COVID-19 Tests...
Can Zinc Really Shorten a Cold?
Every cold and flu season, folks are flooded with ads for zinc lozenges, sprays and syrups that promise to shorten their sniffles. Zinc might indeed reduce...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...